Henry Schein, Inc. (NASDAQ:HSIC) Shares Sold by Wellington Management Group LLP

Wellington Management Group LLP lowered its position in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 17.2% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 32,021 shares of the company’s stock after selling 6,674 shares during the period. Wellington Management Group LLP’s holdings in Henry Schein were worth $2,424,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also recently made changes to their positions in HSIC. JPMorgan Chase & Co. raised its position in Henry Schein by 1.1% in the third quarter. JPMorgan Chase & Co. now owns 4,766,305 shares of the company’s stock valued at $353,898,000 after purchasing an additional 53,506 shares during the period. American Century Companies Inc. lifted its position in Henry Schein by 7.3% in the third quarter. American Century Companies Inc. now owns 4,719,088 shares of the company’s stock valued at $350,392,000 after buying an additional 322,649 shares during the last quarter. Boston Partners boosted its stake in Henry Schein by 144.1% during the fourth quarter. Boston Partners now owns 2,637,429 shares of the company’s stock worth $199,393,000 after buying an additional 1,556,831 shares during the period. Fiduciary Management Inc. WI increased its position in shares of Henry Schein by 17.1% during the fourth quarter. Fiduciary Management Inc. WI now owns 2,284,337 shares of the company’s stock valued at $172,947,000 after acquiring an additional 333,855 shares during the last quarter. Finally, Norges Bank purchased a new stake in shares of Henry Schein in the 4th quarter valued at approximately $111,715,000. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Analyst Ratings Changes

Several analysts recently weighed in on the stock. Piper Sandler reiterated an “overweight” rating and issued a $86.00 target price on shares of Henry Schein in a report on Friday, June 21st. Barrington Research increased their target price on Henry Schein from $90.00 to $92.00 and gave the stock an “outperform” rating in a research note on Wednesday, May 8th. JPMorgan Chase & Co. raised their target price on Henry Schein from $82.00 to $88.00 and gave the company an “overweight” rating in a report on Wednesday, March 6th. Jefferies Financial Group increased their price target on shares of Henry Schein from $74.00 to $81.00 and gave the stock a “hold” rating in a research report on Wednesday, March 6th. Finally, UBS Group dropped their price objective on shares of Henry Schein from $82.00 to $80.00 and set a “neutral” rating for the company in a report on Wednesday, May 8th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and five have given a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $81.73.

Henry Schein Stock Performance

Shares of HSIC stock opened at $64.10 on Monday. The company has a market cap of $8.21 billion, a P/E ratio of 21.66, a PEG ratio of 1.58 and a beta of 0.90. The firm has a fifty day moving average price of $69.91 and a 200 day moving average price of $72.89. The company has a current ratio of 1.75, a quick ratio of 1.02 and a debt-to-equity ratio of 0.47. Henry Schein, Inc. has a 12 month low of $60.01 and a 12 month high of $82.63.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings results on Tuesday, May 7th. The company reported $1.10 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.01 by $0.09. Henry Schein had a return on equity of 13.51% and a net margin of 3.12%. The company had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.21 billion. During the same period in the previous year, the business earned $1.21 EPS. Henry Schein’s revenue for the quarter was up 3.7% on a year-over-year basis. Sell-side analysts predict that Henry Schein, Inc. will post 5.16 earnings per share for the current fiscal year.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.